Sign inGet started

SHALLCROSS STEVEN A

Insider CIK 1263501 · NWGI Director · CMXI SEE REMARKS · VEEE Director · SYN Interim CEO and CFO, Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
TOVX Theriva Biologics, Inc. A Award deriv2026-01-052026-01-06475,000— $0475,000SEC↗
TOVX Theriva Biologics, Inc. A Award deriv2025-04-292025-05-01190,000— $0190,000SEC↗
TOVX Theriva Biologics, Inc. A Award deriv2023-12-142023-12-15700,000— $0700,000SEC↗
TOVX Theriva Biologics, Inc. P Buy2023-06-072023-06-0814,000$0.69 $9.7K250,000SEC↗
TOVX Theriva Biologics, Inc. P Buy2023-06-062023-06-0726,000$0.63 $16.4K236,000SEC↗
ELYS Elys Game Technology, Corp A Award deriv2023-02-142023-02-1639,377— $039,377SEC↗
ELYS Elys Game Technology, Corp A Award deriv2023-02-142023-02-1692,254— $092,254SEC↗
ELYS Elys Game Technology, Corp A Award2023-02-142023-02-1622,472$0.89 $20.0K27,717SEC↗
TOVX Theriva Biologics, Inc. P Buy2023-02-102023-02-1325,000$1.04 $26.0K210,000SEC↗
TOVX Theriva Biologics, Inc. P Buy2023-02-022023-02-0325,000$0.94 $23.5K185,000SEC↗
TOVX Theriva Biologics, Inc. P Buy2023-01-252023-01-2625,000$0.87 $21.8K160,000SEC↗
TOVX Theriva Biologics, Inc. P Buy2023-01-202023-01-2325,000$0.75 $18.8K135,000SEC↗
TOVX Theriva Biologics, Inc. P Buy2022-12-292023-01-03100,000$0.44 $44.0K110,000SEC↗
TOVX Theriva Biologics, Inc. A Award deriv2022-12-152022-12-16475,000— $0475,000SEC↗
SYN Synthetic Biologics, Inc. A Award deriv2021-12-232021-12-27650,000— $0650,000SEC↗
ELYS Elys Game Technology, Corp A Award deriv2021-09-132021-09-1513,600— $013,600SEC↗
VEEE Twin Vee PowerCats, Co. A Award deriv2021-07-232021-07-265,500— $05,500SEC↗
SYN Synthetic Biologics, Inc. P Buy2021-05-102021-05-1050,000$0.49 $24.5K100,000SEC↗
NWGI Elys Game Technology, Corp A Award2021-01-222021-01-275,245$5.72 $30.0K5,245SEC↗
SYN Synthetic Biologics, Inc. A Award deriv2020-12-302020-12-31450,000— $0450,000SEC↗
NWGI Newgioco Group, Inc. A Award deriv2020-10-012020-10-0535,000— $035,000SEC↗
SYN Synthetic Biologics, Inc. A Award deriv2019-12-042019-12-05450,000— $0450,000SEC↗
SYN Synthetic Biologics, Inc. P Buy2019-08-232019-08-2650,000$0.42 $21.0K50,000SEC↗
NWGI Newgioco Group, Inc. A Award deriv2019-07-052019-07-082,500— $082,500SEC↗
NWGI Newgioco Group, Inc. A Award deriv2019-07-052019-07-0882,500— $082,500SEC↗
SYN Synthetic Biologics, Inc. A Award deriv2018-12-062018-12-07200,000— $0200,000SEC↗
SYN Synthetic Biologics, Inc. A Award deriv2017-12-202017-12-21550,000— $0550,000SEC↗
SYN Synthetic Biologics, Inc. A Award deriv2016-11-302016-12-02500,000— $0500,000SEC↗
SYN Synthetic Biologics, Inc. A Award deriv2015-12-042015-12-04100,000— $0100,000SEC↗
SYN Synthetic Biologics, Inc. A Award deriv2015-06-012015-06-01900,000— $0900,000SEC↗
CMXI CYTOMEDIX INC P Buy2014-08-262014-08-2727,500$0.38 $10.4K79,500SEC↗
CMXI CYTOMEDIX INC P Buy2014-08-202014-08-2152,000$0.39 $20.3K52,000SEC↗
CMXI CYTOMEDIX INC A Award deriv2014-04-082014-04-101,219,900— $01,819,900SEC↗
CMXI CYTOMEDIX INC A Award deriv2014-04-082014-06-20300,000— $0900,000SEC↗